Cellular Neuroscience

Special Issues

Following special issues within this section are currently open for submissions:

• Recent Advances in the Understanding of Neuropsychiatric Illnesses (Deadline: 15 July 2026)
• Bioactive Compounds in the Management of Neurodegenerative Diseases (Deadline: 20 July 2026)
• Molecular Mechanisms and Targeting Strategies of the Blood–Brain Barrier (Deadline: 20 July 2026)
• Recent Insights into the Role of Metal Ions in the Nervous System (Deadline: 31 July 2026)
• Sex Differences in Molecular Mechanisms Linking Physiological Stress and Inflammation (Deadline: 31 July 2026)
• The Language of Neural Cells: Decoding Molecular Signaling in Neurodevelopmental and Neuro-Oncological Disorders (Deadline: 31 July 2026)
• AI and Multi-Modal Data Integration in Neurobiology and Neurological Diseases (Deadline: 31 July 2026)
• Tau-Targeted Treatment of Alzheimer’s Disease (Deadline: 31 July 2026)
• Inflammation at the Nexus of Neurodegeneration: Cellular Mechanisms, Biomarkers and Therapeutic Targets (Deadline: 1 August 2026)
• Small-Molecule Approaches to Counteract Demyelination and Neurodegeneration (Deadline: 20 August 2026)
• The Cerebellum: New Neurons, Circuits and Functions (Deadline: 24 August 2026)
• Molecular Mechanisms and Novel Therapeutics for Glioblastoma (Deadline: 25 August 2026)
• New Trends and Advances in Induced Neural Cells and iPSC Technologies (Deadline: 28 August 2026)
• Mechanisms and Biomarkers of Neurotoxicity: From Molecular Pathways to Therapeutic Interventions (Deadline: 31 August 2026)
• State of the Art and Future Prospects in Central Nervous System Cancer Therapeutics (Deadline: 31 August 2026)
• From Inflammaging to Dementia: Cellular and Molecular Drivers of Cognitive Decline (Deadline: 31 August 2026)
• Turning Points in α-Synuclein Biology: From Function to Dysfunction (Deadline: 31 August 2026)
• Recent Discoveries and Progress in Central Nervous System Neuroinflammation (Deadline: 31 August 2026)
• Building the Neurons: Cytoskeleton Dynamics and Organelle Interaction in Health and Disease (Deadline: 1 September 2026)
• Neuroinflammation in Brain Health and Diseases—Second Edition (Deadline: 10 September 2026)
• The Role of Glial Cells in Neurodegenerative Disorders (Deadline: 20 September 2026)
• Role of Transposons in Regulating the Neural Genome and the Mechanisms of Neuropsychiatric Diseases (Deadline: 20 September 2026)
• Molecular and Cellular Drivers of Parkinson's Disease (Deadline: 30 September 2026)
• Epigenetic Regulation in Neuronal Development, Neurodegeneration and Regeneration (Deadline: 30 September 2026)
• Neuron–Glia Synergy and Dysfunction in Parkinson’s Disease (Deadline: 30 September 2026)
• DNA Damage in Neurodegeneration (Deadline: 30 September 2026)
• Human Brain Development: Insights from Experimental and Stem Cell-Based Models (Deadline: 1 October 2026)
• Latest Advances in Molecular and Cellular Mechanisms of Alzheimer's Disease in Canada (Deadline: 10 October 2026)
• Role of Thyroid Hormone in Neurodegenerative and Neurodevelopmental Disorders (Deadline: 30 October 2026)
• Role of Inflammasomes in Neurological Disorders (Deadline: 1 November 2026)
• Molecular Mechanisms and Treatment Strategies in Metabolic Syndromes and Neurological Disorders (Deadline: 20 November 2026)
• Recent Advances in the Study of Tau Protein (Deadline: 25 November 2026)
• Genetic Mechanisms and Pathological Links in Neurodevelopmental Disorders (Deadline: 25 November 2026)
• Advances in Molecular Mechanisms and Modeling of Neuroendocrine Tumors (Deadline: 30 November 2026)
• Brain Insulin Resistance in Neurodegenerative Disorders and Its Treatments (Deadline: 30 November 2026)
• Neuronal Development and Disease: From Molecular Mechanisms to Neurological Disorders—Second Edition (Deadline: 30 November 2026)
• Emerging Roles of Glial Cells in the Nervous System (Deadline: 30 November 2026)
• Beyond Bystanders: The Emerging Roles of Glia in Brain Health and Disease (Deadline: 10 December 2026)
• Cellular Mechanisms and Therapeutic Potentials of Neurodevelopmental Defects (Deadline: 10 December 2026)
• Cell Signaling in Neurodegenerative Disease (Deadline: 10 December 2026)
• Crossroad Between Oxidative Stress and DNA Damage and Repair in Stroke (Deadline: 10 December 2026)
• Therapeutic Targets in Glioblastoma—Second Edition (Deadline: 20 December 2026)
• The Role of Glial Cells in the Nervous System (Deadline: 31 December 2026)
• Inflammation in the Brain: Cellular Interactions, Molecular Pathways and Translation Toward Novel Therapies (Deadline: 15 January 2027)

Topical Collections

Following topical collections within this section are currently open for submissions:

• Beyond Neurotransmission: Emerging Roles of Neurotransmitters in Regulating Morphological, Biochemical, and Functional Properties of Glial and Immune Cells in Healthy and Disease States
• Cell Biology of Spinal Cord Injury and Repair
• Feature Papers in 'Cellular Neuroscience' Section
• How Perinatal Stress Affects Brain Plasticity in Ontogenesis
• Molecular and Behavior Relationship in Gene-Manipulated Model Organisms
• Molecular Insights into Neurodegenerative Diseases
• Molecular Signaling, Circuit Neuroplasticity and the Cognitive Function
• New Insights into the Molecular Mechanisms of Neurodegeneration
• Oligodendrocyte Physiology and Pathology Function
• Spinocerebellar Ataxia (SCA): Molecular Mechanisms and Novel Treatment Strategies
• Stem Cells and Bioengineering for Brain Repair
• The Pathogenesis of Neurological Disorders
• Understanding the Impact of Dopamine Receptors Diversity in the Central Nervous System